Search research articles
Contact Us
Filters
Showing results (11-20 of 80) with videos related to
Page
of 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 24, 2018
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma
Lorenzo Falchi, Alessandra Ferrajoli, Ira Jacobs, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
March 16, 2016
BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia
Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, et al.
Cancer
|
December 31, 2015
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy
Lorenzo Falchi, Srdan Verstovsek, Farhad Ravandi-Kashani, et al.
Leukemia Research
|
April 6, 2017
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review
Prajwal Boddu, Lorenzo Falchi, Chitra Hosing, et al.
Leukemia & Lymphoma
|
June 1, 2012
Chronic lymphocytic leukemia in African Americans
Catherine C Coombs, Lorenzo Falchi, J Brice Weinberg, et al.
Journal of Neuro-Oncology
|
August 22, 2009
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy
Lorenzo Falchi, Marco Gunnellini, Laura Franco, et al.
Rivista Di Psichiatria
|
September 30, 2015
[Murder of the doctor]
Liliana Lorettu, Lorenzo Falchi, Fabrizia L Nivoli, et al.
Journal of Hematology & Oncology
|
January 7, 2021
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Melissa Lumish, Lorenzo Falchi, Brandon S Imber, et al.
Hematological Oncology
|
December 25, 2019
Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials
Helen Ma, Bin Cheng, Lorenzo Falchi, et al.
Cancer Genetics and Cytogenetics
|
May 18, 2010
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution
Lorenzo Falchi, Giovanna Rege-Cambrin, Carmen Fava, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 80) with videos related to
Sort By:
Page
of 8
Clinical Lymphoma, Myeloma & Leukemia
|
June 24, 2018
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma
Lorenzo Falchi, Alessandra Ferrajoli, Ira Jacobs, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
March 16, 2016
BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia
Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, et al.
Cancer
|
December 31, 2015
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy
Lorenzo Falchi, Srdan Verstovsek, Farhad Ravandi-Kashani, et al.
Leukemia Research
|
April 6, 2017
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review
Prajwal Boddu, Lorenzo Falchi, Chitra Hosing, et al.
Leukemia & Lymphoma
|
June 1, 2012
Chronic lymphocytic leukemia in African Americans
Catherine C Coombs, Lorenzo Falchi, J Brice Weinberg, et al.
Journal of Neuro-Oncology
|
August 22, 2009
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy
Lorenzo Falchi, Marco Gunnellini, Laura Franco, et al.
Rivista Di Psichiatria
|
September 30, 2015
[Murder of the doctor]
Liliana Lorettu, Lorenzo Falchi, Fabrizia L Nivoli, et al.
Journal of Hematology & Oncology
|
January 7, 2021
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Melissa Lumish, Lorenzo Falchi, Brandon S Imber, et al.
Hematological Oncology
|
December 25, 2019
Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials
Helen Ma, Bin Cheng, Lorenzo Falchi, et al.
Cancer Genetics and Cytogenetics
|
May 18, 2010
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution
Lorenzo Falchi, Giovanna Rege-Cambrin, Carmen Fava, et al.
Page
of 8